Tilray Brands (TLRY) EBITDA Margin Growth (3y) (2023 - 2026)
Tilray Brands (TLRY) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | 4,301.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 4,301.00 |
| Feb 28, 2026 | 81,610.00 |
| Nov 30, 2025 | 2,569.00 |
| Aug 31, 2025 | 1,482.00 |
| May 31, 2025 | -33,824.00 |
| Feb 28, 2025 | -39,714.00 |
| Nov 30, 2024 | 1,578.00 |
| Aug 31, 2024 | 2,300.00 |
| May 31, 2024 | 4,462.00 |
| Feb 29, 2024 | -2,418.00 |
| Nov 30, 2023 | -150.00 |
| Aug 31, 2023 | -1,221.00 |
| May 31, 2023 | -7,423.00 |